Details of the Drug Reposition

General Information of This Drug (ID: DMM3AI8)

Drug Name
SLx-4090   DMM3AI8
Synonyms SLx 4090; SCHEMBL1484252
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diabetic complication DIS4S2FC 5A2Y Phase 2 [1]
Hyperlipidaemia DIS4R2OG 5C80 Phase 2 [1]
Dyslipidemia DISUYOOU 5C80-5C81 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01675154) Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia. U.S. National Institutes of Health.